Perricone MD
Perricone MD Hypoallergenic CBD Sensitive Skin Therapy Gentle Cleanser
Formulated with 99% pure cannabidiol (CBD), this gentle, low-foaming cleanser is designed to effectively remove dirt and oil without stripping skin of essential moisture. Leaves sensitive skin looking and feeling thoroughly cleansed and moisturized without drying or irritating.
1
Bien
16
Neutre
0
Mise en garde
0
Éviter
6% bien
94% neutre
0% mise en garde
0% éviter
À propos du produit
- Marque
- Perricone MD
- Ingrédients
- 17
- Actifs
- 2
- Code à Barres
-
0651473710691
Survolez une ligne · cliquez pour la carte
Water
Aqua
solvent
→
Glycerin
Glycerol
denaturant hair conditioning humectant oral care perfuming skin conditioning skin protecting solvent viscosity controlling
→
Cocamidopropyl Betaine
antistatic cleansing foam boosting hair conditioning surfactant viscosity controlling
→
Acrylates Copolymer
antistatic binding film forming
→
Sodium Lauroyl Sarcosinate
antistatic cleansing emulsifying foaming hair conditioning skin conditioning surfactant viscosity controlling
→
Polyglyceryl-4 Caprylate/Caprate
hydrotrope surfactant
→
Polyglyceryl-4 Laurate/Sebacate
hydrotrope solvent surfactant
→
Disteareth-75 Ipdi
viscosity controlling
→
Glyceryl Caprylate
emollient emulsifying
→
Cannabidiol
Cannabis Sativa Seed Oil
Hemp Oil
emollient skin conditioning
→
Sodium Hydroxide
lye
buffering denaturant
→
Caprylhydroxamic Acid
chelating
→
Styrene/Acrylates Copolymer
film forming opacifying
→
Sodium Gluconate
chelating skin conditioning
→
Triethyl Citrate
masking perfuming plasticiser
→
Polyquaternium-7
antistatic film forming
→
Состав
Water, Glycerin, Cocamidopropyl Betaine, Acrylates Copolymer, Sodium Lauroyl Sarcosinate, Polyglyceryl-4 Caprylate/Caprate, Polyglyceryl-4 Laurate/Sebacate, Disteareth-75 Ipdi, Glyceryl Caprylate, Cannabidiol, Cannabis Sativa Seed Oil, Sodium Hydroxide, Caprylhydroxamic Acid, Styrene/Acrylates Copolymer, Sodium Gluconate, Triethyl Citrate, Polyquaternium-7
Trouver des produits similaires…
L'historique des modifications n'est pas encore suivi